These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12674196)

  • 1. A study of 24-hour ambulatory blood pressure monitoring in cases of intermittent acute porphyria with hypertension: special reference to safety and efficacy of angiotensin-converting enzyme inhibitor (enalapril) therapy.
    Bandyopadhyay M; Gupta BK; Panwar RB; Kabra PK; Kaushik AN; Chadda VS
    Indian Heart J; 2002; 54(6):734. PubMed ID: 12674196
    [No Abstract]   [Full Text] [Related]  

  • 2. [24-hour ambulatory monitoring of blood pressure in patients with essential hypertension: the effectiveness of enalapril therapy].
    Siegelová J; Fiser B; Dusek J
    Vnitr Lek; 1996 Feb; 42(2):98-101. PubMed ID: 8686198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS Study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145(40):46. PubMed ID: 14603605
    [No Abstract]   [Full Text] [Related]  

  • 4. [ACE inhibitors in the treatment of patients with arterial hypertension and pathology of the digestive system].
    Lazebnik LB; Mikheeva OM; Komissarenko IA; Drozdov VN; Petrakov AV; Sil'vestrova SIu
    Eksp Klin Gastroenterol; 2007; (4):47-55. PubMed ID: 18409490
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enalapril--an oral angiotensin-converting enzyme inhibitor: its pharmacological properties and clinical use].
    Wiecek A; Grzeszczak W
    Pol Tyg Lek; 1988 Feb; 43(9):279-83. PubMed ID: 2841654
    [No Abstract]   [Full Text] [Related]  

  • 6. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
    Jiang XJ; O'Rourke MF; Zhang YQ; He XY; Liu LS
    J Hypertens; 2007 May; 25(5):1095-9. PubMed ID: 17414675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population.
    Shankar PK; Vidyasagar S; Adiga S; Naidu MU; Usha Rani P; Rao D; Bairy KL; Nair S; Jayaprakash B; Shashikiran U; Mukhyapranaprabhu
    Indian J Physiol Pharmacol; 2006; 50(4):421-6. PubMed ID: 17402274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of enalapril to captopril by 24-hour ambulatory blood pressure monitoring.
    Bental T; Lishner M; Lalkin A; Elis A; Ravid M
    J Clin Pharmacol; 1997 Jun; 37(6):514-9. PubMed ID: 9208358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enalapril-clinical experience in Bulgaria].
    Taseva T
    Vutr Boles; 2000; 32(2):27-9. PubMed ID: 11227662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ACE inhibitor. Effective blood pressure control around the clock].
    MMW Fortschr Med; 2001 Sep; 143(35-36):60. PubMed ID: 11584537
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of enalapril. Summing up the evidence.
    Dollery CT
    J Hypertens Suppl; 1983 Oct; 1(1):155-7. PubMed ID: 6100605
    [No Abstract]   [Full Text] [Related]  

  • 16. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of enalapril in the preparation of patients with arterial hypertension to the surgical procedures].
    Proshchaev KI
    Ter Arkh; 2003; 75(12):43-7. PubMed ID: 14959469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new angiotensin-converting enzyme inhibitor is imminent].
    Michel D
    Fortschr Med; 1988 Jul; 106(22):463-6. PubMed ID: 2851512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.